Make an Appointment Contact Us

The Department of Cardiothoracic Surgery is a recognized leader in heart, lung and esophagus surgery. Our experience with complex cardiothoracic issues and knowledge of the latest advances have helped to establish NewYork-Presbyterian|Weill Cornell Medicine as a major referral center for cardiovascular and thoracic patients from around the world.

Cardiac Surgery

The Division of Cardiac Surgery provides expert care to patients who need:

Coronary artery bypass surgery
Valve repair/replacement
Surgery for adult congenital heart disease
Minimally Invasive Heart Surgery
Ventricular Assist Devices (VADs)

Learn More

Thoracic Surgery

The Division of Thoracic Surgery offers the most advanced surgical care for:

Lung and esophageal cancers
Emphysema
Hyperhidrosis
Hiatal hernia
Pericardial & Pleural Effusions
Thoracentesis

Learn More

Cardiac Surgery

Adult & Pediatric

Thoracic Surgery

Lung & Esophagus

Why Choose Weill Cornell?

Make an Appointment Refer a Patient

NewYork-Presbyterian & Weill Cornell Medicine - Cardiothoracic Surgery

New Advances

Valley Health System Participates in First Cardiac Surgery Clinical Trial for Women

Valley Health System is pleased to participate in the ROMA: WOMEN clinical trial, the first cardiovascular surgery clinical trial in women. Valley recently enrolled its first two patients in the trial. Sponsored by Weill Medical College of Cornell University and The Starr Foundation, the trial is designed to determine which bypass graft type is more effective for women with coronary artery disease (CAD) who are undergoing coronary artery bypass grafting (CABG) procedure. Click here to learn more about the article

PCORI Awards $30 Million for a Comparative Study of Surgical Options for Coronary Artery Disease in Underrepresented Patient Populations

Dr. Mario Gaudino

A multi-institutional team of scientists led by Dr. Mario Gaudino, the Stephen and Suzanne Weiss Professor in Cardiothoracic Surgery and assistant dean for clinical trials at Weill Cornell Medicine, has been approved for a nearly $30 million funding award from the Patient-Centered Outcomes Research Institute (PCORI). The award will fund the first study among women and Black and Hispanic patients comparing the effectiveness of two revascularization options used to treat coronary artery disease.

Click here to learn more

WCM Redefines Lung Cancer Treatment with Streamlined Diagnosis and Surgery

Dr. Eugene Shostak . jonathan villena-vargas, thoracic surgery, lung cancer surgeon

For patients diagnosed with early-stage lung cancer, the journey from detection to treatment has traditionally been a prolonged and intricate process. However, Weill Cornell Medicine has introduced an innovative approach that is streamlining the field of lung cancer care. Led by thoracic surgeon Dr. Jonathan Villena-Vargas and interventional pulmonologist Dr. Eugene Shostak, this innovative technique aims to simplify the diagnosis and surgical treatment of lung tumors, providing patients with a more efficient and effective healthcare experience.

The new combined procedure, offers a comprehensive and integrated approach to lung cancer management. By combining cutting-edge technology, unified anesthetic administration, and seamless diagnostic and surgical capabilities, patients now benefit from a rational pathway that consolidates multiple procedures into a single session.

Click here to learn more.

Doing More With Less in Lung Cancer Surgery

Patients with stage 1A non-small cell lung cancer (NSCLC) who undergo surgery to remove a small portion of their lung have outcomes comparable to patients who have surgery removing an entire lobe, according to recent study results. Read More

Clinical Trials

The Cardiothoracic Surgery Department conducts a robust clinical trials program to evaluate the effectiveness of new treatments and medications that have the potential to improve the management of patients with heart, lung, and esophageal disease. The outcomes of heart, lung, and esophageal operations can be improved with technical innovations.